BACKGROUND: Chronic life stress, such as the stress of caregiving, can promote pathophysiology, but the underlying cellular mechanisms are not well understood. Chronic stress may induce recalibrations in mitochondria leading to either changes in mitochondrial content per cell, or in mitochondrial functional capacity (i.e., quality).
INTRODUCTION
Chronic psychological stress is a common human experience that has harmful effects on health and well-being. Years of chronic adversity cause affective, cognitive, behavioral, and metabolic changes that accelerate aging and predispose to disease (1) (2) (3) (4) . Caring for a family member with a chronic condition is an example of a stressful life situation, and in some contexts an independent risk factor for adverse cardiovascular events (5) , dementia (6) , and earlier mortality (7) . However, the cellular mechanisms that underlie these adverse effects remain unclear (2) , and there are likely multiple mechanisms underlying stress-induced pathophysiology and cellular aging (8, 9) . One potential mechanism mediating these effects is mitochondrial dysfunction (10) , since they are known that they play a well-known role in adaptation to stress (11) and aging (12) in animal models. However, mitochondrial health has not been well examined in relation to psychological stress in humans, owing in part to the lack of adequate methods to functionally assess mitochondria, and the need for comprehensive life stress assessments (13) . To bridge this gap, we developed a novel index of mitochondrial health for blood immune cells and applied it to a maternal caregiving model of chronic stress where we tested its sensitivity to daily mood.
Mitochondrial health is emerging as a major determinant of healthy physiological regulation and resilience (14) . Mitochondria are multifaceted organelles and there are hundreds in each cell of the body. They are the cellular powerhouse, providing energy for most cellular functions and generating signals of adaptation that influence the cell's physiological response to stressors (11, 15) . Research in animal models has shown that mitochondrial defects cause profound alterations of stress response axes including the hypothalamic-pituitary-adrenal (HPA) axis and sympathetic activation, which contribute to allostatic load and stress adaptation (11) .
In relation to disease, mitochondria also play a determinant role in cellular life and death (16) , and regulate disease-related processes that overlap with those of chronic stress M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 4 pathophysiology, including inflammation, metabolic regulation, and cellular gene expression (17, 18) . Despite the important role of mitochondria in human health and potential association to stress and psychopathology (19) (20) (21) (22) (23) (24) , currently, methods available have not allowed assessments of mitochondrial health, or "quality", in sizeable human cohorts.
There are different aspects of mitochondrial biology that must be taken into account to obtain an overall measure of mitochondrial health. Mitochondria contain multiple copies of their own genome known as the mitochondrial DNA (mtDNA). The mtDNA is critical for normal mitochondrial function since it encodes components of the respiratory chain complexes, where energy from food substrates and oxygen are transformed into ATP (25). Two main causes of mitochondrial dysfunction are known: i) reduction in the total amount of mitochondria -or mitochondrial content within cells; and ii) reduction in specific mitochondrial energy production capacity -or quality of each mitochondrion. For instance, individuals who inherit mitochondrial disease have a primary reduction in mitochondrial quality, but can exhibit elevated mitochondrial content in blood leukocytes (26) . As a result, mtDNA copy number per cell can be increased as a compensatory mechanism for poor mitochondrial quality (26, 27) , and by itself mtDNA copy number is not a reliable marker of mitochondrial content nor quality. Empirically distinguishing between differences in mitochondrial content and quality is therefore essential to assess mitochondrial health and evaluate its relationship to aging, disease, and life stress exposure.
In this study, we tested the hypothesis that psychological states are associated with mitochondrial health. We first designed a mitochondrial health index (MHI) that mathematically integrates biochemical enzymatic activities and mtDNA copy number measured in parallel into a single score, thus representing mitochondrial functional capacity on a per-mitochondrion basis.
Next, we assessed the MHI in isolated peripheral blood mononuclear cells (PBMCs) in chronically stressed (caregiver) and control women, and combined these data with psychosocial assessment of trait and daily emotional states, measured both prior and after the collection of M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 5 mitochondria (28) . This enabled us to address two primary questions: 1) whether mitochondrial health was associated with perceived stress, negative affect, and daily mood; and 2) whether mitochondrial health was lower in caregivers. A mediation analysis demonstrated that the effect of caregiver status on mitochondrial health is partially mediated by lower daily positive mood.
Overall, our results demonstrate that daily mood influences mitochondrial function, which may contribute to lower leukocyte mitochondrial health in chronically stressed caregivers.
METHODS AND MATERIALS

Study cohort
Data for the present study were derived from a larger longitudinal study focused on the effects of caregiving stress on immunological aging. Individuals were recruited from the San Francisco Bay Area and deemed eligible to participate if they were non-smokers between the ages of 20 and 50 years and had to be the mother of at least one child between the ages of 2 and 16 years. To be characterized as a high-stress maternal caregiver, the participant had to care for a child diagnosed with autism spectrum disorder and report a score of ≥13 on the Perceived Stress Scale (PSS) (29) . In contrast, low-stress maternal controls were characterized as caring for a neurologically typical child and a reported Perceived Stress Scale score of ≤19.
The Perceived Stress Scale eligibility criteria were based on prior national norms (29, 30) .
Structured Clinical Interviews for Diagnostic and Statistical Manual for Mental Disorders for Axis
I Disorders (SCID) were carried out during the eligibility period and individuals with current psychiatric conditions, including bipolar disorder, post-traumatic stress disorder, and eating disorders, were excluded. Substance abuse disorders were also exclusionary. Depression was exclusionary among our control participants; however, this was not exclusionary for high stress caregivers. At the time point at which measures of mitochondrial health were assessed only 2 participants, both high stress caregivers, met diagnostic criteria for depression. Anxiety interviews were re-administered at subsequent study time points. This study was approved by the Institutional Review Board at the University of California, San Francisco, and written informed consent was obtained for each study participant.
Mitochondrial Health Index (MHI) measurements
Platelet-free PBMCs were obtained by differential centrifugation and stored at -80 o C until measurements. All assays were performed on the same biological samples for each subject.
Mitochondria enzymes were selected based on four criteria: i) represent a known biological function (energy production capacity or mitochondrial content), ii) detectable in a microplate format for high-throughput, iii) shown to respond acutely to metabolic and biological stress, iv) encoded by either the mitochondrial or nuclear genomes (see Supplemental Text for detailed information about each component). Enzymatic activities were quantified spectrophotometrically for citrate synthase (CS), cytochrome c oxidase (COX, Complex IV), and succinate dehydrogenase (SDH, Complex II), and expressed as nmol/min/10 6 cells. In parallel, mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) counts were measured by qPCR to normalize for cell numbers and calculate mtDNA copy number. Finally, a composite measure, the Mitochondrial Health Index (MHI) was assessed by mathematically integrating enzymatic activities and mitochondrial DNA copy number, as described in Figure S1 and in the Supplemental Text, which includes a template MHI calculation file.
Stress and mood measures
Psychological stress was measured using the 10-item Perceived Stress Scale (29), depressive symptoms were assessed using the Inventory of Depressive Symptomatology (31), while symptoms of anxiety were measured using the State-Trait Anxiety Inventory (STAI) (32) .
Daily mood was assessed over seven consecutive days using a morning and nightly diary, which encompassed the biological sample collection on Day 4. The nightly diary assessed the intensity of positive (e.g., joy, looking forward to the day, feeling in control) and negative (e.g.,
M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT 7 feeling stressed, worried) affective states, which were derived from the modified Differential Emotions Scale (mDES (33) ). Participants also completed a morning diary upon awakening that assessed positive and negative affective states as well as expectations on the day to come.
Additional details regarding nightly and morning diary measure are provided in the Supplemental Text.
We examined mood on average over the week, and then, to take advantage of the daily data and explore the directionality of effect, we examined mood either before or after the blood draw. Daily mood data were extracted and aggregated as pre-blood draw mood, averaging days 1-3, and as post-blood draw, averaging days 5-7. Therefore, we performed analyses on a dual set of experience data to explore the relationship between mood and MHI.
Data Analysis
Analyses were carried out in four stages. First, we analyzed individual mitochondrial measures and their mathematical integration as MHI. Second, we employed linear regressions to examine across groups whether trait measures of distress or daily mood measured before or after blood draw were related to MHI. Third, analyses of covariance were performed to evaluate group differences between caregiver status (caregiver vs. control) on individual measures of mitochondrial activity (COX, SDH, and CS), mtDNA copy number, and on the composite measure of mitochondrial health (MHI). Finally, we performed mediation analysis to examine if the caregiver difference in MHI was explained in part by differences in trait measures of distress or acute experience in daily affect. Correlation coefficients are computed as Pearson r, unless noted otherwise. For partial least square discriminant analysis (PLS-DA) of MHI components, singular value decomposition (SVD) was used to impute missing values (34) in Metaboanalyst 3.0 (35) , and data was mean-centered and divided by the standard deviation of each variable to scale all variables. All other analyses were conducted using SAS 9.4.
For additional information about the study cohort, inclusion and exclusion criteria, questionnaires and daily mood measures, and complete experimental procedures for mitochondrial enzymatic assays, mtDNA copy number, mitochondrial protein content, and data analysis, the reader is kindly referred to the Supplemental Text.
RESULTS
Demographics
The sample (n = 91) was 43.4 (S.D. = 5.4) years old on average, with a BMI of 25.9 (5.3), and 17.0 (1.8) years of education. There were no significant differences between the caregivers and controls in any demographic factors (Table S1 ). Caregiver duration was on average 5.1 years (S.D. = 3.0, range 1.1 -13.9). Two caregivers met diagnostic criteria for major depression and nine caregivers and one control were taking antidepressants for mood.
This study was not powered to test the association between depression and mitochondrial health, so no conclusion about this potential association can be drawn here. Nevertheless, a sensitivity analysis of the primary analysis excluding those taking antidepressants was conducted, showing no significant effect.
Mitochondrial measurements
For each participant, PBMCs were homogenized and the activities of SDH (Complex II), COX (Complex IV), and CS were measured ( Figure 1A) . The same lysate for each sample was subsequently used to measure mtDNA copy number and to quantify cell number by quantitative real-time PCR (qPCR) (Figure S1 ).
Mitochondrial DNA copy number and mitochondrial content
We first compared across the full study sample two markers of mitochondrial contentor the "number" of mitochondria per cell: mtDNA copy number, and CS enzymatic activity.
Traditionally, mitochondrial enzymatic activity is normalized per total protein content (36), a M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 9 procedure meant to correct for the total number of cells present in each sample. However, protein normalization does not take into account potential differences in total cellular protein density or cell size. When applying this standard procedure, mtDNA copy number and CS were not significantly correlated ( Figure S2A) . We therefore applied qPCR to precisely adjust cell count in each cell lysate and used this metric to normalize enzymatic activity. This method uses a single copy nuclear gene B2m (β 2-microglobulin) to determine relative cell number between samples and generate a correction factor that adjusts cell number per homogenate volume.
When CS was normalized on a per-cell basis using this novel approach, both markers of mitochondrial content were significantly correlated and shared 69% of their variance ( Figure   S2B ), as expected.
We then repeated this analysis for enzymes of the respiratory chain, SDH and COX, two mitochondrial respiratory chain components that contribute to energy production capacity.
Again, when normalized to protein, mtDNAcn was not correlated with SDH nor COX activities, but was significantly correlated when expressed per cell (Figure S2C-F) . These results establish that normalization on a per-cell basis is a superior approach to normalize mitochondrial functional capacity in human PBMCs.
Mitochondrial content vs specific mitochondrial function
Mitochondrial content indexed by CS (37) was then compared to respiratory chain activity for SDH and COX. As expected, inter-individual differences in mitochondrial content accounted for a substantial portion of the variance in total SDH (59%) and COX (64%) activities ( Figure S3A, B) . Comparatively, SDH and COX activities were more weakly correlated to each other and showed only 33% overlap in variance ( Figure S3C ). This indicated that the activities of both enzymes are likely regulated through largely independent mechanisms, consistent with the fact that SDH is entirely encoded by the nucleus, and that COX is partially encoded by the mtDNA. Thus, SDH and COX must contribute mostly independent information about overall 
Development of the Mitochondrial Health Index (MHI)
To develop the composite measure of mitochondrial health, we integrated four functional parameters in a simple equation with two numerators and two denominators, which equally represent the nuclear and mitochondrial genomes. Respiratory chain activity (SDH and COX) are Z-scored and added as the numerator, and markers of mitochondrial content (CS and mtDNA copy number) are also Z-scored and added as the denominator. The quotient of both terms therefore yields a scalar index, the mitochondrial health index (MHI), which reflects respiratory chain capacity per unit of mitochondrial content (see Figure 1B) .
In our cohort, the calculated MHI was normally distributed (D'Agostino & Pearson normality test, K 2 = 4.25, P > 0.10), with a slight positive skew (Skewness = 0.52, Kurtosis = -0.34) ( Figure 1C) . A correlation matrix among all measured and calculated parameters of mitochondrial function showed that all enzyme activities, MHI, and mtDNAcn were most highly related (central cluster), whereas respiratory chain protein levels mostly behave independently from MHI (Figure 1D ). Inter-correlations among the four mitochondrial parameters measured and the MHI index are shown in Table S2 , and the non-significant correlations with BMI and age presented in the Supplemental text.
Comparison of individual measures vs. MHI
To further assess how well the MHI can discriminate between caregivers and controls relative to each of its individual components, we performed a partial least square discriminant analysis (PLS-DA) with caregiver status as the independent variable. We extracted the variable Figure 1E) . VIP scores showed that mitochondrial content (CS and mtDNAcn) were weakest, followed by SDH (nuclear encoded) and COX (mtDNA encoded). Calculated ratios, in which enzymatic activities are normalized to CS, had higher scores than individual components, corroborating the presence of a specific reduction of mitochondrial energy production machinery, rather than a lower mitochondrial content. Of all parameters, the MHI had the highest VIP score on the first component, confirming that the mathematical integration of individual MHI components results in a composite index with superior predictive potential in relation to caregiver status.
Daily mood and mitochondrial health
We then examined the relationship between daily mood and MHI. First, we averaged the mean of positive and negative mood measures across the full week to obtain a trait-like measure. In the evening, higher positive affect was significantly related to higher MHI (r = 0.24, p < 0.05, Figure 2A ). In the morning, there was a trend (P < 0.10) for MHI to be related to greater positive affect (r = 0.21) and lower negative affect (r = -0.19). Then, to understand whether mood had a greater effect on mitochondrial function when it was more proximate to the MHI measurement, we conducted two exploratory analyses examining the association between MHI and daily mood both before and after biological sampling.
Mood was averaged for each individual over the three days before MHI was measured, and compared to the average of the three days after. For mood measures assessed before blood was collected, the cells were present in the body and thus exposed to any biological effects of emotional states. To the extent that mood varies daily within an individual, we expected to see stronger correlations with MHI in the "pre" blood draw mood than the "post" blood draw mood measures. Indeed, for mood measures before the biological sample was taken, we found that positive, but not negative, mood in the morning (r = 0.27, p < 0.05) and evening was significantly associated with higher MHI (r = 0.31, p < 0.01; Figure 2A ). In
contrast, mood measured in the 3 days after sampling was not significantly associated with MHI (p > 0.1).
This time-dependent association is further illustrated by plotting correlation coefficients between daily mood and MHI (measured at Day 4) ( Figure 2B) . The strength of the association between positive mood and MHI appears to become stronger from day 1 to day 3 (only reaching significance for morning mood, on days 1, 2, and 3), reaching highest values (morning: r = 0.28, night: r = 0.35) the day immediately preceding blood draw for mitochondrial measurements.
Thus, nightly mood on Day 3 alone accounts for approximately 12.3% of the variance of MHI on Day 4. None of the mood scores measured after the collection of PBMCs were correlated with MHI, and correlation coefficients appeared to regress towards zero for these time points ( Figure   2B ). The effect of negative mood was not significant when examined as separate days. This temporal association between positive mood and MHI suggests that the cells that were circulating during the experience of positive mood tended to have higher mitochondrial energy production capacity.
Lastly, we examined MHI in tertiles of positive and negative nightly mood across the whole sample. As shown in Figure 3 , there was evidence for a 'dose response' relationship between positive mood and higher MHI. Negative mood at night was also related to with lower MHI. Individuals with the highest positive mood and/or lowest levels of negative mood had the highest MHI levels. The lowest and highest mood tertiles had MHI values that differed by 16-18%.
Caregiver and control group comparison
Caregivers had significantly higher reported levels of perceived stress, depressive symptoms, and trait anxiety than controls ( Table 1) . Caregivers also showed lower levels of daily positive affect and higher negative affect over the week, both upon waking and at night ( Table 2) . Across the study sample, there were no significant associations between MHI and
measures of distress (perceived stress, depressive symptoms, and anxiety) ( Table S3 ). There was only a trend suggesting higher levels of depressive symptoms with lower MHI, in the expected direction (p = 0.10). But there are relatively few individuals with high depression scores, and only two caregivers met criteria for major depression (none in the severe range), making this study not adequately powered to assess the association between depression and
MHI.
To test the hypothesis that caregivers have lower mitochondrial health, we used standard ANCOVA models to examine caregiver versus control group differences in enzymatic activities, mtDNA copy number, and MHI. Table 3 displays age-adjusted group means across key mitochondrial outcomes. Individual components of the MHI yielded no statistically significant group differences on their own. However, the MHI was significantly lower in caregivers compared to controls, indicating lower mitochondrial respiratory chain activity per unit of mitochondria. This is also apparent in Figure 1C , where a greater proportion of caregivers have lower MHI, and only controls have high MHIs >150. This result illustrates the sensitivity of the composite MHI over individual components of the index in relation to caregiver stress, and indicates lower mitochondrial quality, but not content, in caregivers.
Does daily mood mediate MHI in caregivers?
Given the temporal association between mood and mitochondrial function, and the differences in mood between groups, we reasoned that the differences in MHI between caregivers and controls could partially be explained by daily mood. To test this possibility, we ran a series of multiple regression models to test the indirect effects of caregiver status on MHI, via mood from days preceding the blood draw. Table 4 , in the total effect model (40) caregiver group status is a significant predictor of MHI for both morning and nightly positive mood. This showed an indirect effect of
As shown in
nightly positive mood (β = -5.12, p < 0.05; Figure S6 ), suggesting that low positive nightly mood before the blood draw may be partly responsible for the lower MHI measured in caregivers relative to control subjects.
Exploration of reasons for the group differences
One possible cause of lower MHI in caregivers is that they have an "imbalance", or mismatch between the amount of proteins synthesized by the mitochondrial and nuclear genomes, which is known to result from abnormal intracellular communication and influence the aging process (38, 39) . Comparing the balance of proteins levels for mtDNA-encoded COX II and nuclear-encoded complex I and II subunits in controls and caregivers separately indicated that differences in MHI between caregivers and controls were unlikely due to altered communication between mitochondria and the cell nucleus ( Figure S5) . The number of days since last menstrual period was also unrelated to MHI (r = -0.01, p = 0.96).
As enzymatic activities could be affected by freezer storage time, we also evaluated duration in the freezer as a potential confounding variable. There was a significant correlation between storage time and MHI (r = -0.56, p < 0.001), as well as with positive mood, perceived stress, anxiety and depression (please see Supplemental text for analyses and discussion).
This made it impossible to selectively covary out storage time across the whole sample without removing the effect of the group variable. But in the caregiver group, the correlation between MHI and positive mood remained significant and of similar effect size when adjusted for storage time compared to the unadjusted correlation that did not account for freezer time, indicating that although the association between daily mood and MHI is invariant to freezer time, this may have contributed to the group difference.
DISCUSSION
There are multiple pathways by which chronic stress can impact health. Here we developed a new way to quantify this relationship by combining biochemical and molecular mitochondrial components in human blood leukocytes. This method, the mitochondrial health index (MHI), integrates measures of both mitochondrial content and functional capacity assessed from the same samples. We first confirmed the sensitivity of this method and tested the hypothesis that mood is associated with leukocyte mitochondrial health. Collectively, our findings demonstrate three main points: i) The integrative MHI is an indicator of mitochondrial functional capacity with superior sensitivity to chronic stress and mood than individual mitochondrial measures; ii) Chronic caregiving stress is associated with lower mitochondrial respiratory chain capacity, but not mitochondrial content; iii) Daily mood may partially mediate the effects of caregiving stress on mitochondria.
Despite growing evidence that aging-and stress-related diseases involve mitochondrial dysfunction (18, 41, 42) , this hypothesis has remained difficult to test in sizeable human cohorts.
Recent studies have found that life history of depression and early life adversity are associated with greater mtDNA copy number measured in whole blood (19, 20) . However, other studies have found a fewer, rather than greater, mtDNA copy number with post-traumatic stress disorder (21) , depression (22) , and in the elderly (43) . In addition, early life trauma has also been linked to changes in cellular baseline oxygen consumption measured in cryopreserved whole cells (23) . But such measurements could reflect differences in cellular energy demand rather than intrinsic differences in the actual functional capacity of mitochondria. Maximal mitochondrial energy production capacity is more directly quantified in fresh permeabilized cells (44) or, as in the current study, by the maximal rate of key enzymatic activities such as COX and SDH (45) .
Limitations of studies measuring only mtDNA copy number -not the activity or functional outputs from mitochondria -is that while potentially indicating mitochondrial recalibrations, the It is therefore difficult to interpret when measured alone.
Furthermore, measures in whole blood are confounded by cellular composition. Differences in platelet number substantially alter apparent mtDNA copy number without affecting leukocyte mitochondrial function (46, 47) . Thus, the biological significance of variation in whole blood mtDNA copy number alone is unclear. In general, laboratory methods currently available to assess the functionality of mitochondria typically require a substantial amount of fresh tissues, involve specialized equipment, have low throughput, and do not readily allow researchers to distinguish between differences in mitochondrial content versus functional capacity.
The MHI addresses these limitations and represents specific mitochondrial energy production capacity on a per-mitochondrion basis -or mitochondrial quality -showing evidence that mitochondria respond to psychological stress and mood states. These results are consistent with animal studies on the effects of acute and chronic stress on mitochondrial structure and function (13) . More research is required to replicate and extend the current findings in humans, and to identify the interacting psychobiological mechanisms that may transduce chronic psychosocial stress into changes in mitochondrial health.
Some limitations of the current study must be noted. Though using mothers caring for a child with autism spectrum disorder is a well-established stress model, it could be confounded by an underlying predisposition to mitochondrial dysfunction. This limitation applies only to the finding on group differences, not to the findings relying on within-person differences in mood across the week, which demonstrates a temporal relationship whereby between emotional states predict 10-15% of the variance in next day MHI. Furthermore, although a substantial advance over single mitochondrial measurements, it must be recognized that the four- Another technical limitation of this study is the use of mixed leukocyte populations in PBMCs, as opposed to sorted leukocytes lineages, which may contain different mitochondrial phenotypes (48) . Furthermore, the potential confound of freezer storage time in relation to the caregivercontrol group difference underscores the importance for future studies of leukocyte enzymatic activities and mitochondrial health to explicitly analyze storage time by clinical/experimental groups. Future studies should also strive to comprehensively assess multiple facets of mitochondrial biology from homogenous leukocyte populations, in cohorts comprising of both women and men.
In summary, we present a novel scalable approach to quantify mitochondrial health and establish the extend of inter-individual variability in human leukocyte mitochondrial function.
Using this approach, we found a directional effect of mood on mitochondria, which mediated in part the effect of caregiver status on MHI. Chronic caregiving stress is associated with lower mitochondrial energy production capacity, but not content. These results are consistent with the adverse effects of psychological stress on multiple physiological systems, with mitochondria representing a potential site for the biological embedding of chronic stress exposure. 
A Mitochondrial Health Index Sensitive to Mood and Caregiving Stress
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Supplemental FIGURES S1 -S6.
Supplemental TABLES S1 -S3.
Supplemental METHODS AND MATERIALS:
Additional methodological details about the study cohort, recruitment procedures, the blood draw procedures, the complete description of experimental procedures used to measure the mitochondrial enzymatic activities and mtDNA copy number, mitochondrial protein content, daily mood measures, and data analysis. TABLES S1 -S3 Diagnosis of depression was based on SCID. All participants reported being premenopausal and in good general health with no major diseases, including no history of coronary heart disease, endocrine disorders, epilepsy, brain injury, autoimmune conditions, severe asthma or lung disease. Potential participants were excluded if they reported a history of cancer or had undergone chemotherapy or radiation in the past 10 years. Low-stress maternal controls with current major depression were excluded; however, given the high base rate of depression among high stress caregivers this was not exclusionary in high-stress maternal caregivers. All study participants were free from medications known to affect the immune and endocrine system. With the exception of antidepressant medication and oral contraceptives, all study participants were free from medications known to affect the immune and endocrine system, including cholesterol altering medication (e.g., statins), regular use of anti-anxiety medications (e.g., benzodiazepines), and corticosteroid medications. Use of anti-hypertensive medication, such as beta-blockers, was not exclusionary.
Participants were screened by self-report symptoms of infection prior to the blood draw and rescheduled if the participant reported experiencing an acute illness or showed evidence of a fever (>37.8C). White blood cell count was also performed, which if elevated above 10,500/μL, is indicative of an acute infection. However, we did not observe any participants who met this criterion.
Participants were paid $110 at the conclusion of the baseline assessment. At nine months after recruitment, we drew blood to examine mitochondrial health in PBMCs, in a random subset of 91 Table S1 .
Antidepressant use was not significantly correlated with MHI, but because more caregivers were taking antidepressants, we examined this potential confound in a sensitivity analysis by filtering out the ten participants who reported using antidepressants. This results showed the same pattern of significant results in MHI group differences (means age adjusted: 88.44 vs. 104.51, t(72)= 2.52, P < .05). Furthermore, we carried out Structured Clinical Interviews for Diagnostic and Statistical Manual for Mental Disorders for Axis I Disorders (SCID) to assess past history of depression which revealed that 31 participants (20 caregivers, 11 controls) had a past history of depression. MHI was unrelated to past history of depression status (t(82) = 1.15, p = 0.26). Potential participants were excluded if they reported substance abuse disorders, a history of cancer or had undergone chemotherapy or radiation in the past 10 years. Individuals with current psychiatric conditions, including bipolar disorder, posttraumatic stress disorder and eating disorders were also excluded. Low-stress maternal controls with current major depression were excluded; however, given the high base rate of depression among high stress caregivers this was not exclusionary in high-stress maternal caregivers. We re-administered the SCID at each of the study time points, including the 9-month time point to assess the current psychiatric conditions. At the 9-month time point, only 2 participants (both caregivers) met diagnostic criteria for major depression. was moderately strong r = 0.59, and the pre-post correlation between negative morning mood was 0.58.
Similarly, nightly mood was significantly correlated between the pre-and post-blood draw periods (positive mood, r = 0.60, negative mood, r = 0.65). One would expect these moderately strong intercorrelations of mood would reduce the probability of detecting pre-post differences in the mood-MHI association. Nevertheless, these results showed that only mood measured before MHI was significant, and that the strength of this association increased the more proximal it was to blood collection, indicating a potential directional effect of mood on mitochondria within days. This exciting finding is in need of replication.
Given the temporal association between mood and mitochondrial function, we reasoned that the differences in MHI between caregivers and controls could partially be explained by individual differences in daily mood. Indeed, caregivers have less positive and more negative daily mood ( Table 2) . To test this possibility, we ran a series of multiple regression models to test the indirect effects of caregiver status on MHI, via mood. Because we were testing in a post hoc fashion whether the already observed effect of mood before the draw mediated the relationship between stress group and MHI, we examined only positive mood and only in the pre-blood draw days. : Not a respiratory chain enzyme, located in the mitochondrial matrix and used as a marker of mitochondrial content.
Indices of
N/A: Not applicable
Mitochondrial Enzymatic Assays and mtDNA Copy Number. Five million PBMCs were homogenized in 0.4ml of extraction buffer containing 1mM EDTA and 50mM triethanolamine. To detect enzymatic activity, the absorbance of a specific reporter dye in each reaction was monitored over time, non-specific activity subtracted, and the final enzyme activity calculated from the first derivative and molar extinction coefficient for the reporter dye (6) . Biochemical methods were adapted from previously published protocols for cells and tissues, with some modifications (6, 7) . All measurements were performed in a 96-well plate format with the assay run in triplicates for each enzyme, along with a nonspecific activity control. mtDNA copy number was determined in triplicates, on two plates in parallel, using multiplex qPCR chemistry that simultaneously amplifies a mitochondrial (ND1) and a nuclear (RNAseP) amplicon to determine their relative abundance (8, 9) . The sequences for the ND1 amplicon (IDT) are as follows: Thereafter, the C.V. was 0.5% (plate 1) and 0.4% (plate 2). For nDNA the average C.V. was 0.5% (plate 1) and 0.3% (plate 2). After curating the C.V. were 0.4% (plate 1) and 0.3% (plate 2). mtDNA copy number was calculated as mtDNAcn = [2 (RNAseP Ct -ND1 Ct) ] x 2, taking into account the diploid nature of the nuclear genome. Results from the two plates were averaged to yield final mtDNAcn values, expressed as the number of mtDNA copies per cell.
Respiratory chain activity was normalized in two ways: i) to protein concentration obtained by the bicinchoninic acid assay (BCA) method, and ii) to relative cell count obtained by qPCR for the RNAseP (nDNA) amplicon. As expected, correlation analyses between enzymatic activities and mtDNAcn showed that normalization to cell number was a more sensitive normalization procedure.
To compute the Mitochondrial Health Index (MHI), enzymatic activities and mtDNA copy number were z-scored so that each parameter has equal weight in the final equation. SDH and COX are added at the numerator, and CS and mtDNA copy number are added at the denominator (Fig. S1 ). The final MHI reflects mitochondrial energy production capacity per mitochondrial unit, on a per-cell basis.
For analyzes of individual functional parameters (CS, COX, SDH) and mtDNA copy number, variables were log transformed to reduce skewness; all values were within -/+ 4 standard deviation range. For all analyses, the MHI was analyzed using its original untransformed units. entries, 80 participants completed entries for the entire week (i.e., 7 days), while some (n=11) provided partial data (range = 3-6 records). For missing data, analyses were performed allowing for listwise deletion of the cases above. All statistical analyses were performed in SAS 9.4.
SUPPLEMENTAL RESULTS AND DISCUSSION
Mitochondrial Respiratory Chain Protein Levels. Individual protein subunits for each of the five respiratory chain complexes I-V were then quantified by Western blotting (Figure S4A) . We again evaluated the relationship between mtDNA-encoded and nuclear-encoded proteins: COX subunit 2 (COX II) and SDH subunit B (SDHB), respectively. They were strongly correlated, with 58% of shared variance (Figure S4B) . However, there was little correlation between COX II protein abundance and COX enzymatic activity (Figure S4C) modifications, etc). By profiling respiratory chain proteins, we also identified individuals in the cohort (< 5-10%) with idiosyncratic respiratory chain protein patterns with missing subunits (Figure S4D) , although the current sample size did not enable reliable interpretation of this observation.
Assessment of Covariates.
We evaluated the correlation between measures of mitochondrial health and age, as well as potential covariates including body mass index (BMI), and regular antidepressant (AD) medication use. These covariates were not significantly correlated with any individual measures, or with the MHI, except for a weak association of BMI and SDH (r = -.22, p < .05). The correlations with MHI were as follows: age, r = .12, BMI, r = -.02, and regular antidepressant medication use, r = -.10, all non-significant. In this sample, even though there was a limited age span of twenty years, age is retained as a covariate in all subsequent analyses since it is theoretically a likely cause of poor mitochondrial health.
Mediation Model. The full effect model includes a simultaneous regression including both caregiver group and mood, and the covariate age. Because negative mood was not significantly associated with MHI ( Figure 4 ), we focused our analyses on positive mood. Including positive mood in the model weakened the effect of caregiver group. The main effect of caregiver group was still significant for morning (p = 0.040), but it was no longer significant for nightly mood (p = 0.063). Nightly positive mood was a significant predictor of lower MHI with caregiver group. We then tested the indirect effect of positive mood on MHI in the adjusted model, with results reported in Table 4 and Figure S6 . Since the distribution of the indirect effect based on the product of two coefficients was non-normal, we assessed significance using a bias-corrected bootstrap confidence intervals with 5,000 samples. Though the caregiver and control groups showed average differences in mood, they also overlap. The relation between mood and MHI can therefore be examined within each group separately to see if the MHI correlates with mood while covarying out the effect of freezer storage time. The correlation between MHI and positive mood in the caregiver group remained significant and of similar effect size when adjusted for storage time (r = 0.30, p = 0.04), compared to the unadjusted correlation that did not account for freezer time (r = 0.29, p = 0.05). However, this relationship was not significant for the control group alone, either adjusted for freezer time or raw, likely due to the limited range of values and sample size. Taken together, these results suggest that although the association between daily mood and MHI is not influenced by storage time, part of the group difference may be. Enzymatic activities may be more sensitive to storage time than static molecular markers and future studies should take this into account in their study design. 
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